As of June 18, 2025, Almirall SA (ALM.MC) reports a Forward P/E of 35.13.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Almirall SA's Forward P/E to Peers
To better understand Almirall SA's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Almirall SA (ALM.MC) | 35.13 |
| HUTCHMED (China) Ltd (HCM.L) | 5601.09 |
| ECO Animal Health Group PLC (EAH.L) | 3901.40 |
| Dechra Pharmaceuticals PLC (DPH.L) | 3038.99 |
| Alliance Pharma PLC (APH.L) | 1284.82 |
| Hikma Pharmaceuticals PLC (HIK.L) | 1234.85 |
Compared to its competitors, Almirall SA's Forward P/E is about average compared to peers, indicating growth expectations in line with industry peers.